DF
Daniel Faga
President, CEO

Daniel Faga insider trades: Anaptysbio (ANAB) stock sales

President, CEO, Anaptysbio Last trade Jan 7, 2026 35 Form 4 filings
$1.1M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2017
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Daniel reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 7, 2026ANAB↓ Sell$415K
Jan 5, 2026ANAB↓ Sell$662K
Mar 25, 2024ANAB↓ Sell$3.4M
Jan 8, 2024ANAB↓ Sell$150K
Feb 2, 2021MRTX↓ Sell$260K
Jan 7, 2021MRTX↓ Sell$568K
Oct 24, 2017ONCE↓ Sell$607K
Sep 19, 2017ONCE↓ Sell$128K
Sep 12, 2017ONCE↓ Sell$495K
Sep 7, 2017ONCE↓ Sell$255K
Jul 24, 2017ONCE↓ Sell$210K
Jun 29, 2017ONCE↓ Sell$282K
May 15, 2017ONCE↓ Sell$256K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ANAB insiders

Open-market trades in the last 12 months

About Daniel Faga's insider trades

Daniel Faga is President, CEO at Anaptysbio (ANAB). Since May 15, 2017, Daniel has reported no open-market purchases and 13 sales worth $7.7M on SEC Form 4. In the last 12 months: 2 sales ($1.1M).

Their filings also include grants and awards (20 filings), option exercises (15 filings), shares withheld for taxes (5 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANAB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.